+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Sodium Hyaluronate Intra-Articular Injection Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6082075
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Sodium Hyaluronate Intra-Articular Injection Market is projected to reach USD 2.23 Billion in 2026. It is expected to continue growing at a CAGR of 10.54%, reaching USD 4.07 Billion by 2032.

Sodium Hyaluronate Intra-Articular Injection: Executive Overview

Sodium hyaluronate intra-articular injections are used primarily for symptomatic management of osteoarthritis-related joint pain, especially in the knee. The treatment is administered directly into a joint and is positioned within a broader care pathway that may include exercise, weight management, oral or topical medicines, physical therapy, and surgery. Clinical practice varies because treatment response, guideline recommendations, product characteristics, reimbursement, and patient preferences differ across healthcare systems.

Clinical Practice Is Shifting Toward Evidence-Based, Patient-Centered Use

The landscape is being reshaped by stronger emphasis on comparative clinical evidence, appropriate patient selection, and shared decision-making. Providers increasingly assess symptom severity, radiographic findings, comorbidities, prior treatments, functional goals, and willingness to undergo invasive procedures before recommending injection therapy. Attention is also increasing on injection technique, infection prevention, treatment intervals, documentation of outcomes, and the distinction between short-term symptom relief and disease modification. Reimbursement policies and evolving professional guidance remain important determinants of access and utilization.

Artificial Intelligence Supports Selection, Workflow, and Outcome Monitoring

Artificial intelligence can contribute to this field through imaging-assisted osteoarthritis assessment, identification of patients at risk of progression, clinical decision support, and prediction of treatment response. It may also improve scheduling, inventory management, consent documentation, and follow-up monitoring through digital symptom and mobility tracking. However, algorithmic outputs require clinical validation across diverse populations, transparent performance reporting, protection of patient data, and clinician oversight. AI should support-not replace-individual assessment and informed consent, particularly where evidence about injection response is heterogeneous.

Regional Insights: Access and Guidance Vary Across Six Healthcare Landscapes

North America is characterized by substantial outpatient procedural capacity, payer scrutiny, and active debate over comparative effectiveness and appropriate indications. Europe combines established musculoskeletal services with country-level variation in reimbursement and clinical guidance. Asia-Pacific includes advanced markets with mature orthopedic care alongside rapidly expanding healthcare access and uneven availability of specialist services. Latin America is shaped by public-private system differences, affordability considerations, and concentration of specialist care in major urban centers. The Middle East continues to develop orthopedic and rehabilitation infrastructure, with access influenced by public investment and private provision. Africa faces wider disparities in diagnostic capacity, specialist availability, and reimbursement, making integrated primary, orthopedic, and rehabilitation pathways especially important.

Group Insights: Economic and Policy Blocs Shape Adoption Conditions

ASEAN markets reflect diverse regulatory systems, healthcare financing models, and specialist capacity, with urban centers generally better positioned to provide injection-based care. BRICS members encompass large and varied patient populations, but access differs according to national insurance coverage, local manufacturing capability, and regional healthcare infrastructure. The European Union benefits from shared regulatory principles while retaining substantial variation in reimbursement and clinical implementation. G7 countries generally have strong procedural capacity and extensive evidence-generation systems, alongside cost-effectiveness and guideline scrutiny. GCC states often combine high investment in specialist care with differing public and private access pathways. NATO members span multiple health systems, so common security ties do not eliminate variation in procurement, reimbursement, or clinical practice.

Country Insights: National Systems Determine Clinical Access and Use

Australia and Canada pair established orthopedic services with geographic access challenges and public-system prioritization. Brazil and Mexico show strong private-sector activity alongside uneven public access and regional concentration of specialists. China and India combine large demand for osteoarthritis care with major differences between metropolitan and rural services; local regulatory and reimbursement conditions remain influential. France, Germany, Italy, and Spain operate within European frameworks but differ in prescribing norms, payer processes, and availability of rehabilitation and specialist services. Japan and South Korea have advanced aging-care and orthopedic infrastructures, with national policy shaping clinical adoption. Russia’s access is influenced by public procurement, domestic healthcare capacity, and regional variation. The United Kingdom places strong emphasis on evidence appraisal, commissioning, and pathway-based care. The United States has broad procedural availability but considerable variation by insurer policy, clinician practice, and patient out-of-pocket exposure.

Actions for Leaders: Improve Evidence, Delivery, and Patient Selection

Industry leaders should prioritize high-quality comparative studies that define which patient profiles, joints, disease stages, and treatment intervals are most likely to benefit. Standardized outcome measures covering pain, function, mobility, adverse events, and duration of relief can strengthen clinical and payer discussions. Providers should establish clear eligibility criteria, injection protocols, infection-control procedures, and follow-up pathways linked to rehabilitation and conservative care. Organizations operating across regions should adapt evidence-generation and access strategies to local reimbursement, regulatory, and workforce conditions. Digital and AI tools should be introduced only with governance, bias testing, cybersecurity safeguards, and clinician accountability. Patient education should clearly explain expected benefits, alternatives, uncertainties, and when escalation to other interventions may be appropriate.

Research Methodology: Evidence-Based Review of a Multidimensional Care Market

This executive summary is based on a structured review framework for sodium hyaluronate intra-articular injection, combining clinical literature, professional guidance, regulatory information, reimbursement documentation, healthcare-system context, and regional and country-level access factors. Findings are organized around treatment use, clinical decision-making, technology adoption, policy conditions, and delivery infrastructure. Sources should be assessed for publication quality, recency, population relevance, methodological limitations, and consistency across jurisdictions. Because recommendations and coverage policies can change, conclusions should be periodically refreshed and interpreted alongside local clinical and regulatory requirements.

Conclusion: Responsible Integration Is Central to Sustainable Clinical Value

Sodium hyaluronate intra-articular injection remains part of a broader osteoarthritis-management pathway rather than a standalone solution. Its role is shaped by patient selection, clinical evidence, procedural quality, rehabilitation access, reimbursement, and national guidance. The most durable progress will come from aligning treatment decisions with patient goals, improving outcome measurement, reducing unwarranted geographic variation, and using digital and AI capabilities responsibly. Leaders who combine rigorous evidence with practical, equitable care pathways will be better positioned to deliver clinically meaningful value across diverse healthcare systems.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Sodium Hyaluronate Intra-Articular Injection Market, by Indication
7.1. Introduction
7.2. Osteoarthritis
7.2.1. Ankle
7.2.2. Hip
7.2.3. Knee
7.2.4. Shoulder
7.3. Rheumatoid Arthritis
8. Sodium Hyaluronate Intra-Articular Injection Market, by Product Type
8.1. Introduction
8.2. Cross-Linked
8.3. Native
9. Sodium Hyaluronate Intra-Articular Injection Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Hospitals
9.4. Specialty Clinics
10. Sodium Hyaluronate Intra-Articular Injection Market, by Distribution Channel
10.1. Introduction
10.2. Institutional Sales
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Sodium Hyaluronate Intra-Articular Injection Market, by Frequency Of Administration
11.1. Introduction
11.2. Multiple Injections
11.3. Single Injection
12. Sodium Hyaluronate Intra-Articular Injection Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Sodium Hyaluronate Intra-Articular Injection Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Sodium Hyaluronate Intra-Articular Injection Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Aetos Pharma Private Limited
16.2. Altergon
16.3. Anika Therapeutics, Inc.
16.4. Arthrex, Inc.
16.5. Bioventus Inc.
16.6. Bloomage Biotech
16.7. Channel-Markers Medical LLC
16.8. Chong Kun Dang Pharmaceutical Corp.
16.9. Contipro a.s.
16.10. DongKook Pharm Co., Ltd.
16.11. Dr. Reddy’s Laboratories Ltd.
16.12. Ferring Pharmaceuticals B.V.
16.13. Fidia Farmaceutici S.p.A.
16.14. LG Chem, Ltd.
16.15. Nichi-Iko Pharmaceutical Co., Ltd.
16.16. Sanofi S.A.
16.17. SciVision Biotech Inc.
16.18. Seikagaku Corporation
16.19. Shanghai Haohai Biological Technology Co., Ltd.
16.20. Zimmer Biomet Holdings, Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Sodium Hyaluronate Intra-Articular Injection Market, Years Considered for the Study
FIGURE 2. Global Sodium Hyaluronate Intra-Articular Injection Market, Research Design
FIGURE 3. Global Sodium Hyaluronate Intra-Articular Injection Market, Research Framework
FIGURE 4. Global Sodium Hyaluronate Intra-Articular Injection Market, Data Triangulation
FIGURE 5. Global Sodium Hyaluronate Intra-Articular Injection Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 7. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2025 vs 2032 (%)
FIGURE 15. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Sodium Hyaluronate Intra-Articular Injection Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Sodium Hyaluronate Intra-Articular Injection Market Segmentation & Coverage
TABLE 2. Global Sodium Hyaluronate Intra-Articular Injection Market Size, 2017-2032 (USD Million)
TABLE 3. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 4. Global Osteoarthritis Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Osteoarthritis Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Osteoarthritis Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Ankle Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Ankle Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Ankle Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Hip Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Hip Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Hip Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Knee Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Knee Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Knee Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Shoulder Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Shoulder Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Shoulder Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Rheumatoid Arthritis Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Rheumatoid Arthritis Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Rheumatoid Arthritis Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 23. Global Cross-Linked Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Cross-Linked Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Cross-Linked Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Native Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Native Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Native Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 30. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 40. Global Institutional Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Institutional Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Institutional Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 50. Global Multiple Injections Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Multiple Injections Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Multiple Injections Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Single Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Single Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Single Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Sodium Hyaluronate Intra-Articular Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 64. North America Sodium Hyaluronate Intra-Articular Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. North America Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 66. North America Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 67. North America Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 68. North America Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 69. North America Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 70. North America Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 71. Latin America Sodium Hyaluronate Intra-Articular Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Latin America Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 73. Latin America Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 74. Latin America Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 75. Latin America Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 76. Latin America Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 77. Latin America Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 78. Europe Sodium Hyaluronate Intra-Articular Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Europe Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 80. Europe Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 81. Europe Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 82. Europe Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. Europe Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 84. Europe Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 85. Middle East Sodium Hyaluronate Intra-Articular Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Middle East Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 87. Middle East Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 88. Middle East Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 89. Middle East Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. Middle East Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 91. Middle East Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 92. Africa Sodium Hyaluronate Intra-Articular Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Africa Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 94. Africa Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 95. Africa Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 96. Africa Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. Africa Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 98. Africa Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 99. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. ASEAN Sodium Hyaluronate Intra-Articular Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. ASEAN Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 102. ASEAN Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 103. ASEAN Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 104. ASEAN Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. ASEAN Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. ASEAN Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 107. GCC Sodium Hyaluronate Intra-Articular Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. GCC Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 109. GCC Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 110. GCC Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 111. GCC Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. GCC Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 113. GCC Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 114. European Union Sodium Hyaluronate Intra-Articular Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. European Union Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 116. European Union Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 117. European Union Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 118. European Union Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. European Union Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 120. European Union Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 121. BRICS Sodium Hyaluronate Intra-Articular Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. BRICS Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 123. BRICS Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 124. BRICS Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 125. BRICS Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. BRICS Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 127. BRICS Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 128. G7 Sodium Hyaluronate Intra-Articular Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. G7 Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 130. G7 Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 131. G7 Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 132. G7 Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. G7 Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 134. G7 Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 135. NATO Sodium Hyaluronate Intra-Articular Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. NATO Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 137. NATO Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 138. NATO Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 139. NATO Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. NATO Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 141. NATO Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 142. Global Sodium Hyaluronate Intra-Articular Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. United States Sodium Hyaluronate Intra-Articular Injection Market Size, 2017-2032 (USD Million)
TABLE 144. United States Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 145. United States Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 146. United States Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 147. United States Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. United States Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 149. United States Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 150. Canada Sodium Hyaluronate Intra-Articular Injection Market Size, 2017-2032 (USD Million)
TABLE 151. Canada Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 152. Canada Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 153. Canada Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 154. Canada Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. Canada Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 156. Canada Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 157. Mexico Sodium Hyaluronate Intra-Articular Injection Market Size, 2017-2032 (USD Million)
TABLE 158. Mexico Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 159. Mexico Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 160. Mexico Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 161. Mexico Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. Mexico Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 163. Mexico Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 164. Brazil Sodium Hyaluronate Intra-Articular Injection Market Size, 2017-2032 (USD Million)
TABLE 165. Brazil Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 166. Brazil Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 167. Brazil Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. Brazil Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. Brazil Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 170. Brazil Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 171. United Kingdom Sodium Hyaluronate Intra-Articular Injection Market Size, 2017-2032 (USD Million)
TABLE 172. United Kingdom Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 173. United Kingdom Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 174. United Kingdom Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 175. United Kingdom Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. United Kingdom Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 177. United Kingdom Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 178. Germany Sodium Hyaluronate Intra-Articular Injection Market Size, 2017-2032 (USD Million)
TABLE 179. Germany Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 180. Germany Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 181. Germany Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 182. Germany Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. Germany Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 184. Germany Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 185. France Sodium Hyaluronate Intra-Articular Injection Market Size, 2017-2032 (USD Million)
TABLE 186. France Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 187. France Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 188. France Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 189. France Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. France Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 191. France Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 192. Russia Sodium Hyaluronate Intra-Articular Injection Market Size, 2017-2032 (USD Million)
TABLE 193. Russia Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 194. Russia Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 195. Russia Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 196. Russia Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. Russia Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 198. Russia Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 199. Italy Sodium Hyaluronate Intra-Articular Injection Market Size, 2017-2032 (USD Million)
TABLE 200. Italy Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 201. Italy Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 202. Italy Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 203. Italy Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. Italy Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 205. Italy Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 206. Spain Sodium Hyaluronate Intra-Articular Injection Market Size, 2017-2032 (USD Million)
TABLE 207. Spain Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 208. Spain Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 209. Spain Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 210. Spain Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. Spain Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 212. Spain Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 213. China Sodium Hyaluronate Intra-Articular Injection Market Size, 2017-2032 (USD Million)
TABLE 214. China Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 215. China Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 216. China Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 217. China Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. China Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 219. China Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 220. India Sodium Hyaluronate Intra-Articular Injection Market Size, 2017-2032 (USD Million)
TABLE 221. India Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 222. India Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 223. India Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 224. India Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. India Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 226. India Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 227. Japan Sodium Hyaluronate Intra-Articular Injection Market Size, 2017-2032 (USD Million)
TABLE 228. Japan Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 229. Japan Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 230. Japan Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 231. Japan Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. Japan Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 233. Japan Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 234. Australia Sodium Hyaluronate Intra-Articular Injection Market Size, 2017-2032 (USD Million)
TABLE 235. Australia Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 236. Australia Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 237. Australia Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 238. Australia Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. Australia Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 240. Australia Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 241. South Korea Sodium Hyaluronate Intra-Articular Injection Market Size, 2017-2032 (USD Million)
TABLE 242. South Korea Sodium Hyaluronate Intra-Articular Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 243. South Korea Sodium Hyaluronate Intra-Articular Injection Market Size, by Osteoarthritis, 2017-2032 (USD Million)
TABLE 244. South Korea Sodium Hyaluronate Intra-Articular Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 245. South Korea Sodium Hyaluronate Intra-Articular Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. South Korea Sodium Hyaluronate Intra-Articular Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 247. South Korea Sodium Hyaluronate Intra-Articular Injection Market Size, by Frequency Of Administration, 2017-2032 (USD Million)
TABLE 248. Global Sodium Hyaluronate Intra-Articular Injection Market Share, by Key Player, 2025
TABLE 249. Global Sodium Hyaluronate Intra-Articular Injection Market, Key Experts

Companies Mentioned

  • Aetos Pharma Private Limited
  • Altergon
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • Bioventus Inc.
  • Bloomage Biotech
  • Channel-Markers Medical LLC
  • Chong Kun Dang Pharmaceutical Corp.
  • Contipro a.s.
  • DongKook Pharm Co., Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Ferring Pharmaceuticals B.V.
  • Fidia Farmaceutici S.p.A.
  • LG Chem, Ltd.
  • Nichi-Iko Pharmaceutical Co., Ltd.
  • Sanofi S.A.
  • SciVision Biotech Inc.
  • Seikagaku Corporation
  • Shanghai Haohai Biological Technology Co., Ltd.
  • Zimmer Biomet Holdings, Inc.